Skip to main content
BCPC
NASDAQ Industrial Applications And Services

Balchem Q2 2026: Sales Jump 11% to $284M, EPS $1.39; Credit Facility Expanded to $650M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Chemical Stocks · Materials
Sentiment info
Positive
Importance info
7
Price
$167.555
Mkt Cap
$5.384B
52W Low
$139.17
52W High
$183.9
52W Position info
20% above low
Off High info
8.9% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

BCPC sits 20% above its 52-week low of $139.17.

Summary

Balchem posted record Q2 results with sales of $284M (+11% YoY) and EPS of $1.39, beating expectations. The credit facility was upsized to $650M, extending runway for strategic initiatives.


Key Events · Earnings and Guidance · BCPC

  • Q2 Sales and Earnings Beat

    Net sales rose 11% to $284M, with all three segments growing. Diluted EPS was $1.39, up from $1.17 a year ago, driven by higher volumes and favorable mix.

  • Credit Facility Upsized to $650M

    Amendment No. 1 increased the revolving commitment from $550M to $650M and extended maturity to July 2031, enhancing liquidity for growth and acquisitions.

  • Share Repurchases Continue

    The company repurchased $44.5M of common stock in H1 2026 under its December 2025 program, with 3.66M shares remaining authorized.

  • Working Capital Build

    Inventories increased to $161.6M from $131.4M at year-end 2025, reflecting higher raw material and finished goods levels to support demand.


Analysis · BCPC · Industrial Applications And Services

A broad-based beat marked Balchem's Q2, with sales climbing 11% to $284M and adjusted EPS of $1.49 topping consensus. All three segments contributed to the growth, led by a 15% surge in Animal Nutrition & Health. The company also amended its credit agreement, boosting the revolver to $650M and pushing maturity out to 2031, which provides ample liquidity for growth and acquisitions. Share repurchases continued, with $44.5M spent in H1. The strong quarter and enhanced financial flexibility reinforce the company's solid operating momentum.

How filings like this one have moved

In the 30 days to Oct 1, 2026, 30.1% of the 1612 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.53%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BCPC was trading at $167.56 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5.4B. The 52-week trading range was $139.17 to $183.90. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BCPC - Latest Insights

BCPC
Jul 31, 2026, 7:32 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $163.50
Real-time Price: $163.39 info
Change: -$0.115 (-0.07%) info
Market Cap: $5.208B info
BCPC
Jul 31, 2026, 7:13 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $163.50
Real-time Price: $163.39 info
Change: -$0.115 (-0.07%) info
Market Cap: $5.208B info
BCPC
Apr 30, 2026, 7:34 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $173.33
Real-time Price: $163.39 info
Change: -$9.95 (-6%) info
Market Cap: $5.208B info
BCPC
Apr 30, 2026, 7:25 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $173.33
Real-time Price: $163.39 info
Change: -$9.95 (-6%) info
Market Cap: $5.208B info
BCPC
Feb 20, 2026, 4:26 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $172.00
Real-time Price: $163.39 info
Change: -$8.62 (-5%) info
Market Cap: $5.208B info